Bredden K, Lechner K
Z Gastroenterol. 1976 Mar;14 Suppl:202-10.
Part I: Immunological assays of clotting factors in the diagnosis of liver diseases. The immunological determination of Antithrombin III is a good measure of the capacity of the liver to synthesize plasma proteins. Antithrombin III concentration in serum correlated significantly with the prothrombin time and the activity of cholinesterase. The immunological determination of factor VIII related antigen seems to be important for the early recognition of the transition of an acute hepatitis into a chronic course. While following uncomplicated acute hepatitis the level of factor VIII related antigen is normal after 40 weeks, it remains high in cases which become chronic. Immunological assay of factor XIII seems to be not very useful in the diagnosis of liver diseases. Part II: Management of coagulation disturbances in liver diseases. Except cases of hepatic coma the hemostatic abnormalities in chronic liver diseases are rarely severe enough that correction is necessary. Prothrombin concentrates are considered by most of the discussants as unnecessary and potentially dangerous. Transfusion of platelets is only neccessary when the platelet count is below 40.000 and surgery is planned. It is uncertain whether patients with chronical liver disease and laboratory signs of DIC benefit from heparin therapy. Although laboratory tests may be improved, prognosis, especially in cases of acute oesophageal bleeding, seems to be not changed by this treatment.
凝血因子的免疫测定在肝病诊断中的应用。抗凝血酶III的免疫测定是衡量肝脏合成血浆蛋白能力的良好指标。血清中抗凝血酶III的浓度与凝血酶原时间及胆碱酯酶活性显著相关。VIII因子相关抗原的免疫测定对于早期识别急性肝炎向慢性病程的转变似乎很重要。在无并发症的急性肝炎患者中,40周后VIII因子相关抗原水平恢复正常,而转为慢性的患者该抗原水平仍保持较高。XIII因子的免疫测定在肝病诊断中似乎用处不大。第二部分:肝病凝血功能障碍的处理。除肝昏迷病例外,慢性肝病中的止血异常很少严重到需要纠正的程度。大多数讨论者认为凝血酶原浓缩物没有必要且有潜在危险。只有当血小板计数低于40,000且计划进行手术时才需要输注血小板。慢性肝病且有弥散性血管内凝血实验室指标的患者是否能从肝素治疗中获益尚不确定。尽管实验室检测可能有所改进,但这种治疗似乎并未改变预后,尤其是在急性食管出血的病例中。